Rapport Therapeutics, Inc (RAPP) insider trading
Every open-market stock purchase and sale by Rapport Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $39.6M over the last 12 months (23 sales). No open-market buys.
- Last insider buy: Steven M Paul (Insider), $693K, 13 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $39.6M (23 sales). Last close $36.68 on Jun 7, 2026.
Recent RAPP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 10, 2026 | Wendy B. Young (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | James Healy (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Reid M Huber (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | John Maraganore (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Steven M Paul (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Robert J Perez (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Ramiro Sanchez (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Paul M Silva (Insider) | Bought (not open market) | — |
| May 26, 2026 | Third Rock Ventures V L.P. (Insider) | Sold | $744K |
| May 11, 2026 | Third Rock Ventures V L.P. (Insider) | Sold | $5.4M |
| May 8, 2026 | Third Rock Ventures V L.P. (Insider) | Sold | $202K |
| May 7, 2026 | Third Rock Ventures V L.P. (Insider) | Sold | $10.9M |
| Apr 17, 2026 | Third Rock Ventures V L.P. (Insider) | Sold | $17.2M |
| Apr 17, 2026 | Krishnaswamy Yeleswaram (C-suite exec) | Sold | $809K |
| Apr 14, 2026 | Krishnaswamy Yeleswaram (C-suite exec) | Sold | $358K |
| Apr 13, 2026 | Krishnaswamy Yeleswaram (C-suite exec) | Sold | $321K |
| Apr 10, 2026 | Krishnaswamy Yeleswaram (C-suite exec) | Sold | $17.5K |
| Apr 8, 2026 | Krishnaswamy Yeleswaram (C-suite exec) | Sold | $12.6K |
| Mar 30, 2026 | Cheryl Gault (COO) | Sold | $201K |
| Mar 30, 2026 | Cheryl Gault (COO) | Sold | $81.1K |
| Mar 25, 2026 | Krishnaswamy Yeleswaram (C-suite exec) | Sold | $303K |
| Mar 5, 2026 | Cheryl Gault (COO) | Sold | $58.3K |
| Feb 19, 2026 | David Bredt (C-suite exec) | Bought (not open market) | — |
| Feb 18, 2026 | Abraham Ceesay (CEO) | Sold | $103K |
| Feb 18, 2026 | Abraham Ceesay (CEO) | Sold | $86.6K |
Who's trading RAPP
- Wendy B. Young, Insider: other filings, last Jun 10, 2026
- James Healy, Director: other filings, last Jun 10, 2026
- Reid M Huber, Insider: other filings, last Jun 10, 2026
- John Maraganore, Insider: other filings, last Jun 10, 2026
- Steven M Paul, Insider: other filings, last Jun 10, 2026
- Robert J Perez, Insider: other filings, last Jun 10, 2026
- Ramiro Sanchez, Insider: other filings, last Jun 10, 2026
- Paul M Silva, Insider: other filings, last Jun 10, 2026
- Third Rock Ventures V L.P., Insider: sold $34.4M (5 sales), last May 26, 2026
- Krishnaswamy Yeleswaram, C-suite exec: sold $1.9M (7 sales), last Apr 17, 2026
- Cheryl Gault, COO: sold $491K (4 sales), last Mar 30, 2026
- David Bredt, C-suite exec: sold $1.4M (12 sales), last Feb 19, 2026
- Abraham Ceesay, CEO: sold $1.5M (20 sales), last Feb 18, 2026
- Jeffrey Sevigny, C-suite exec: other filings, last Feb 2, 2026
- Troy A. Ignelzi, CFO: other filings, last Feb 2, 2026
Get free alerts when an insider at Rapport Therapeutics, Inc files a new trade →